Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |